BioCentury
ARTICLE | Company News

WHO to start treatment with Merck's Ebola vaccine

May 17, 2018 11:01 PM UTC

The World Health Organization said Thursday it plans to begin administering Ebola vaccine rVSV-ZEBOV (V920) in the Democratic Republic of the Congo "as soon as possible." WHO noted that 4,300 doses of the Merck & Co. Inc. (NYSE:MRK) vaccine are already in the region and an additional 7,540 doses are being shipped to the African nation.

The vaccine is being given as part of an expanded access protocol, according to Merck, which has a stockpile of more than 300,000 emergency use dose equivalents. WHO declared the situation an “outbreak” on May 8 (see BioCentury Extra, May 14)...

BCIQ Company Profiles

Merck & Co. Inc.